1. Home
  2. NNVC vs MASK Comparison

NNVC vs MASK Comparison

Compare NNVC & MASK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNVC
  • MASK
  • Stock Information
  • Founded
  • NNVC 2005
  • MASK 2017
  • Country
  • NNVC United States
  • MASK Hong Kong
  • Employees
  • NNVC N/A
  • MASK N/A
  • Industry
  • NNVC Biotechnology: Pharmaceutical Preparations
  • MASK
  • Sector
  • NNVC Health Care
  • MASK
  • Exchange
  • NNVC Nasdaq
  • MASK NYSE
  • Market Cap
  • NNVC 22.5M
  • MASK 27.7M
  • IPO Year
  • NNVC N/A
  • MASK 2025
  • Fundamental
  • Price
  • NNVC $1.39
  • MASK $1.75
  • Analyst Decision
  • NNVC
  • MASK
  • Analyst Count
  • NNVC 0
  • MASK 0
  • Target Price
  • NNVC N/A
  • MASK N/A
  • AVG Volume (30 Days)
  • NNVC 238.4K
  • MASK 108.4K
  • Earning Date
  • NNVC 05-15-2025
  • MASK 01-01-0001
  • Dividend Yield
  • NNVC N/A
  • MASK N/A
  • EPS Growth
  • NNVC N/A
  • MASK 12.16
  • EPS
  • NNVC N/A
  • MASK 0.19
  • Revenue
  • NNVC N/A
  • MASK $4,718,055.00
  • Revenue This Year
  • NNVC N/A
  • MASK N/A
  • Revenue Next Year
  • NNVC N/A
  • MASK N/A
  • P/E Ratio
  • NNVC N/A
  • MASK $11.07
  • Revenue Growth
  • NNVC N/A
  • MASK 7.89
  • 52 Week Low
  • NNVC $0.94
  • MASK $1.60
  • 52 Week High
  • NNVC $2.55
  • MASK $4.19
  • Technical
  • Relative Strength Index (RSI)
  • NNVC 50.72
  • MASK N/A
  • Support Level
  • NNVC $1.34
  • MASK N/A
  • Resistance Level
  • NNVC $1.44
  • MASK N/A
  • Average True Range (ATR)
  • NNVC 0.09
  • MASK 0.00
  • MACD
  • NNVC 0.00
  • MASK 0.00
  • Stochastic Oscillator
  • NNVC 77.14
  • MASK 0.00

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

About MASK 3 E NETWORK TECHNOLOGY GROUP LTD

3 E Network Technology Group Ltd is a business-to-business (B2B) information technology (IT) business solutions provider. It focuses on integrated software and hardware solutions in the property management and exhibition services spaces and expanded software solutions offering to a variety of industries and sectors, including food establishments, real estate, exhibition & conferencing, and clean energy utilities. The business includes two main portfolios, namely the software development portfolio and exhibition and conference portfolio. Maximum revenue is generated from the software development portfolio.

Share on Social Networks: